Gomekli: A Breakthrough in Treating Neurofibromatosis Type 1 with Plexiform Neurofibromas
Gomekli (mirdametinib) has become the first FDA-approved treatment for both adults and children with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas (PN)—tumors that often cannot be surgically removed. While…